You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

regorafenib

Showing 51 - 75 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Metastatic, mCRC Trial in El Segundo (biological, drug, procedure)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • mCRC
  • Aldoxorubicin Hydrochloride
  • +19 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 28, 2022

Cancer of the Bile Duct Trial in Tampa, Chapel Hill, Richmond (Regorafenib)

Completed
Has Results
  • Cancer of the Bile Duct
  • Regorafenib
  • Tampa, Florida
  • +2 more
Sep 20, 2021

Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma Trial in Duarte

Active, not recruiting
  • Advanced Colon Adenocarcinoma
  • +24 more
  • Ipilimumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Aug 22, 2022

Hepatocellular Carcinoma, Regorafenib, PD-1 Inhibitor Trial in Beijing (Regorafenib, PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Regorafenib
  • PD-1 inhibitor
  • Beijing, Beijing, China
    Hai-Tao Zhao
Sep 15, 2021

Regorafenib in Taiwan Metastatic Colorectal Cancer Patients

Completed
  • Metastatic Colorectal Cancer
  • Regorafenib
  • Taipei, Taiwan
    Taipei Veterans General Hospital
Jul 21, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • regorafenib
  • laboratory biomarker analysis
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Metastatic Colorectal Adenocarcinoma Trial in United States (Regorafenib)

Active, not recruiting
  • Metastatic Colorectal Adenocarcinoma
  • Regorafenib
  • Basking Ridge, New Jersey
  • +6 more
Oct 28, 2021

Ewing Sarcomas, Chondrosarcomas, Osteosarcomas Trial in France (Regorafenib, Placebo)

Recruiting
  • Ewing Sarcomas
  • +4 more
  • Regorafenib
  • Placebo
  • Besancon, France
  • +18 more
Apr 1, 2022

Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,

Active, not recruiting
Has Results
  • Colon Adenocarcinoma
  • +8 more
  • Clobetasol Propionate
  • +3 more
  • Phoenix, Arizona
  • +21 more
Jan 5, 2022

Advanced and Metastatic Solid Tumor Trial in Kashiwa (Regorafenib, Nivolumab)

Completed
  • Advanced and Metastatic Solid Tumor
  • Kashiwa, Chiba, Japan
    NationalCCHE
Apr 23, 2021

Metastatic Solid Malignancies, Locally Advanced Solid Malignancies Trial in Edmonton (Regorafenib)

Withdrawn
  • Metastatic Solid Malignancies
  • Locally Advanced Solid Malignancies
  • Regorafenib
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 18, 2021

BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma Trial in United States

Recruiting
  • BRAF V600E Negative
  • +12 more
  • Cetuximab
  • +3 more
  • Scottsdale, Arizona
  • +15 more
Aug 23, 2022

Molecular Predictors of Resistance and Response to Regorafenib

Completed
  • Metastatic Colorectal Cancer
  • Regorafenib
  • Carshalton, Surrey, United Kingdom
    The Royal Marsden NHS Foundation Trust London and Surrey
Apr 30, 2021

Melanoma Trial in Seoul (regorafenib)

Recruiting
  • Melanoma
  • regorafenib
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 1, 2021

Advanced Cancers Trial in Houston (Regorafenib, Cetuximab, Questionnaire)

Completed
  • Advanced Cancers
  • Regorafenib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 31, 2021

Pretreated Metastatic Colorectal Cancer Trial in Mainz (TAS 102, Regorafenib)

Completed
  • Pretreated Metastatic Colorectal Cancer
  • TAS 102
  • Regorafenib
  • Mainz, Germany
    Universitätsmedizin Mainz, I.Medizinische Klinik und Poliklinik
Mar 25, 2021

Advanced Colorectal Cancer Trial in Benevento, Napoli, Potenza (regorafenib)

Active, not recruiting
  • Advanced Colorectal Cancer
  • regorafenib
  • Benevento, Italy
  • +3 more
Mar 3, 2021

Ovarian Carcinoma Trial in France (Tamoxifen, Regorafenib)

Active, not recruiting
  • Ovarian Carcinoma
  • Angers, France
  • +25 more
Oct 6, 2021

Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Hepatic Artery Infusion Chemotherapy
  • +3 more
  • (no location specified)
Feb 7, 2022

Regorafenib Plus Programmed Cell Death-1 Inhibitors in Advanced

Active, not recruiting
  • Advanced Colorectal Carcinoma
  • Regorafenib
  • +6 more
  • Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Feb 23, 2021

Advanced Cancer Trial in Randwick (CS1003, Regorafenib)

Completed
  • Advanced Cancer
  • CS1003
  • Regorafenib
  • Randwick, New South Wales, Australia
    Scientia Clinical Research Ltd
Feb 17, 2022

Metastatic Colorectal Cancer Trial in Guangzhou (MAX-40279-01, regorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Nov 22, 2021

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023